552 related articles for article (PubMed ID: 16616115)
1. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
Lin P; Medeiros LJ; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24).
Lin P; Lennon PA; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2009 Sep; 193(2):119-22. PubMed ID: 19665075
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.
Park TS; Cheong JW; Song J; Choi JR
Leuk Res; 2009 Jul; 33(7):1001-4. PubMed ID: 19155067
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
[TBL] [Abstract][Full Text] [Related]
8. Translocation (3;21)(q26;q22) in secondary leukemia. Report of two cases and literature review.
Schneider NR; Bowman WP; Frenkel EP
Ann Genet; 1991; 34(3-4):256-63. PubMed ID: 1809236
[TBL] [Abstract][Full Text] [Related]
9. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
[TBL] [Abstract][Full Text] [Related]
10. Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.
Xu X; Su M; Levy NB; Mohtashamian A; Monaghan S; Kaur P; Zaremba C; Garcia R; Broome HE; Dell'Aquila ML; Wang HY
Leuk Lymphoma; 2014 Nov; 55(11):2532-7. PubMed ID: 24397594
[TBL] [Abstract][Full Text] [Related]
11. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Rubin CM; Larson RA; Anastasi J; Winter JN; Thangavelu M; Vardiman JW; Rowley JD; Le Beau MM
Blood; 1990 Dec; 76(12):2594-8. PubMed ID: 2265251
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
13. t(1;3)(p36;p21) is a recurring therapy-related translocation.
Sato Y; Izumi T; Kanamori H; Davis EM; Miura Y; Larson RA; Le Beau MM; Ozawa K; Rowley JD
Genes Chromosomes Cancer; 2002 Jun; 34(2):186-92. PubMed ID: 11979552
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Sakugawa M; Kojima K; Kaneda K; Masuda K; Dansako H; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M; Tanimoto M
Ann Hematol; 2001 Dec; 80(12):763-6. PubMed ID: 11797121
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
Aktas D; Tuncbilek E
Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
[TBL] [Abstract][Full Text] [Related]
18. Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: case report and review of the literature.
Voutsadakis IA; Maillard N
Am J Hematol; 2003 Feb; 72(2):135-7. PubMed ID: 12555218
[TBL] [Abstract][Full Text] [Related]
19. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.
Nishiyama M; Arai Y; Tsunematsu Y; Kobayashi H; Asami K; Yabe M; Kato S; Oda M; Eguchi H; Ohki M; Kaneko Y
Genes Chromosomes Cancer; 1999 Nov; 26(3):215-20. PubMed ID: 10502319
[TBL] [Abstract][Full Text] [Related]
20. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Kawakami K; Watanabe Y; Kadowaki S
Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
